Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 2 APO E - CI - CII haplotype distribution in CAD and control subjects.

From: Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease

Haplotype

Control

CAD

E2 - H1 - A1

0.0107

-

E2 - H1 - A2

-

-

E2 - H2 - A1

0.0342

0.0191

E2 - H2 - A2

-

0.0183

E3 - H1 - A1

0.4155

0.4107

E3 - H1 - A2

0.4216

0.4446

E3 - H2 - A1

0.0167

0.0196

E3 - H2 - A2

0.0160

-

E4 - H1 - A1

0.0596

0.03836

E4 - H1 - A2

0.0072

-

E4 - H2 - A1

0.0180

0.0247

E4 - H2 - A2

-

0.0244

P

0.922

 
  1. P: Probability values for the comparison of haplotype frequencies between controls and CAD.
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X